Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2023 |
Reihe/Periodikum: | The Lancet Regional Health - Europe ; volume 27, page 100592 ; ISSN 2666-7762 |
Verlag/Hrsg.: |
Elsevier BV
|
Schlagwörter: | Health Policy / Oncology / Internal Medicine |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27582545 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1016/j.lanepe.2023.100592 |